[Dangers and potential uses of enzyme stimulating medication on newborns and infants].
D000632:Aminopyrine / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D002701:Chloramphenicol / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D004357:Drug Synergism; D004790:Enzyme Induction / Q000187:drug effects*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007567:Jaundice, Neonatal / Q000517:prevention & control; D008099:Liver / Q000378:metabolism; D010634:Phenobarbital / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D011247:Pregnancy; D013268:Stimulation, Chemical
D000632:Aminopyrine; D002701:Chloramphenicol; D010634:Phenobarbital
Gefahren und Möglichkeiten von enzymstimulierenden Medikamenten im Neugeborenen- und Säuglingsalter.